Plasma Exchange Treatment Improves Prognosis of Antineutrophil Cytoplasmic Antibody-associated Crescentic Glomerulonephritis: A Case-Control Study in 26 Patients from a Single Center

Therapeutic Apheresis

Volumn 7, Issue 6, 2003, Pages 540-546

  Frascà, Giovanni M ^a   Soverini, Maria Letizia ^a   Falaschini, Alessandra ^a   Tampieri, Elena ^a   Vangelista, Alba ^a   Stefoni, Sergio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

ANCA; Crescentic glomerulonephritis; Microscopic polyangiitis; Plasma exchange; Vasculitis; Wegener's granulomatosis

Indexed keywords

CYCLOPHOSPHAMIDE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ARTICLE; CADAVER; CASE CONTROL STUDY; CLINICAL FEATURE; CRESCENTIC GLOMERULONEPHRITIS; DIALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS;

ADULT; AGE FACTORS; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PLASMA EXCHANGE; PROBABILITY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

EID: 0345732702     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2003.00089.x     Document Type: Article

References (22)

1. Hoffman GS, Kerr GS, Leavitt RY et al. Wegener granulomatosis, an analysis of 158 patients, Ann Intern Med 1992:116:488-98.
2. Gaskin G, Pusey CD. Systemic vasculaitis. In: Cameron JS, Grunfeld J, Kerr DNS, Ritz E. Winearls CG, eds. Oxford Textbook of Clinical Nephrology, 2nd edn. Oxford: Oxford University Press, 1998;877-99.
3. Falk RJ, Hogan S, Carey TS, Jennette JC. Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. Ann Intern Med 1990;113:656-63.
4. Fauci AS, Haynes BF, Katz P, Wolf SM. Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
5. Jennette JC, Falk RJ, Antineutrophil cytoplasmic autoantibody-associated diseases: a review. Am J Kidney Dis 1990;15:517-29.
6. Balow JE. Renal vasculitis. Kidney Int 1985;27:954-64.
7. Harper L, Savage COS. Pathogenesis of ANCA-associated systemic vasculitis. J Pathol 2000;190:349-59.
8. Pusey CD, Rees AJ, Evans DJ, Peters DK, Lockwood CM. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 1991;40:757-63.
9. Levy JB, Pusey CD. Still a role for plasma exchange in rapidly progressive glomerulonephritis. J Nephrol 1997;10:7-13.
10. Guillevin L, Cevalos R, Durand-Gasselin B, Lhote F, Jarrousse B, Callard P. Treatment of glomerulonephritis in microscopic polyangiitis and Churg-Strauss syndrome. Indications of plasma exchange: Meta-analysis of 2 randomized studies on 140 patients, 32 with glomerulonephritis. Ann Med Interne (Paris) 1997:148:198-204.
11. Gaskin G, Pusey CD. Plasmapheresis in antineutrophil cytoplasmic antibodies-associated systemic vasculitis. Ther Apher 2001;5:176-81.
12. Rasmussen N, Jayne DRW, Abramowicz D et al. European therapeutic trials in ANCA-associated systemic vasculitis: Disease scoring, consensus regimen and proposed clinical trials. Clin Exp Immunol 1995;101:29-34.
13. Jennette JC, Falk RJ, Andrassy K et al, Nomenclature of systemic vasculitides: Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
14. , Norusis MJ. SPSS/PC+4.0 Base and advanced statistics manuals. Chicago: SPSS Inc., 1990.
15. Andrassy K, Erb A, Koderisch J, Waldherr R, Ritz E, Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy and renal outcome. Clin Nephrol 1991;35:139-47.
16. Grotz W, Wanner C, Keller E et al. Crescentic glomerulonephritis in Wegener's granulomatosis: morphology, therapy, outcome. Clin Nephrol 1991;35:243-51.
17. Frascà GM, Zoumparidis NG, Borgnino LC et al. Combined treatment in Wegener's granulomatosis with crescentic glomerulonephritis. Clinical course and long-term outcome. Int J Artif Organs 1993;16:11-19.
18. Coward RA, Hamdy NA, Shortland JS, Brown CB. Renal micropolyarteritis: a treatable condition. Nephrol Dial Transplant 1986:1:31-7.
19. Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ. Prognostic markers in patients with anti-neutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996:7:23-32.
20. De Groot K, Adu D, Savage COS. The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant 2001;16:2018-27.
21. Lockwood CM, Thiru S, Stewart S et al. treatment of refractory Wegener's granulomatosis with humanised monoclonal antibodies. Q J Med 1996:89:903-12.
22. Stone JH, Uhlfelder ML, Hellmann DB, Crook S, Bedocs NM, Hoffman GS. Etanercept combined with conventional treatment in Wegener's granulomatosis: a six months open-label trial to evaluate safety. Arthritis Rheum 2001;44:1149-54.